The increase in life expectancy of individuals living with HIV has contributed to the manifestation of comorbidities due to multiple factors, such as HIV infection, use of antiretroviral drugs and aging. The use of other drugs and polypharmacy can compromise adherence to antiretroviral treatment due to potential drug interactions and adverse reactions. A cohort study was conducted with individuals living with H...
Goal: In this study, we aimed to monitor the blood glucose, urea, and creatinine laboratory tests in treatment-naive individuals, initiating ART with an antiretroviral regimen containing EFV or DTG, searching for a contribution to the understanding of the safety of these drugs in use in the real world, followed up for 72 weeks. Methods: Cohort study with a follow-up of people living with HIV initiating antiretr...
Prospective cohort of people living with HIV who started combination antiretroviral therapy (cART) with regimens containing efavirenz (EFV) or dolutegravir (DTG) in three specialized HIV/AIDS care services in Belo Horizonte, Brazil, with the objective of analyzing incidence, time to development and factors associated with the first adverse drug reaction (ADR). Data were collected from September 2015 to October ...
Introdução: Pessoas vivendo com HIV (PVHA) devem ser devidamente orientadas para iniciar a terapia antirretroviral (TARV), sendo importante identificar as dificuldades de PVHA com o tratamento, no intuito de realizar intervenções para prevenir uma possível falha terapêutica. Objetivos: Desenvolver uma escala para avaliar a percepção de dificuldades de PVHA com a TARV e analisar sua validade de conteúdo. Métodos...